Build an opioid stewardship program that protects patients and ensures compliance


Opioid management is a complex responsibility for hospital pharmacists. Medication errors involving high-risk drugs, particularly opioids, can lead to adverse drug events, patient harm, and increased liability. At the same time, maintaining compliance with The Joint Commission standards, state regulations, and Board of Pharmacy requirements is resource-intensive and prone to audit risk. With only 41% of hospitals operating an active opioid stewardship program (OSP), many organizations lack the real-time visibility and standardized processes needed to identify risk before it reaches the patient.

Sentri7 Opioid Stewardship addresses these challenges by using evidence-based rules and clinically maintained algorithms to deliver real-time patient-specific milligram equivalent (MME) calculations, which help pharmacists pinpoint opportunities to optimize medication selection, dose, and course of action. It surfaces high-risk patients proactively, so pharmacy teams can act quickly, promote multi-modal therapies, and reduce the likelihood of opioid-related adverse events, all within their existing clinical workflow.

The result is a measurable improvement in both compliance and patient outcomes. Health systems can view opioid use, prescribing patterns, and interventions across the enterprise to support governance and demonstrate alignment with Joint Commission expectations for safe opioid prescribing. By documenting each clinical intervention, pharmacy leaders can also quantify their impact and reinforce a culture of safety.

Guide safer opioid prescribing with evidence-based risk identification

From compliance tracking to intervention documentation, Sentri7 supports clinicians' capacity to optimize prescribing, protect patients, and keep aligned with The Joint Commission standards.

  • Best in KLAS ranks Wolters Kluwer’s Sentri7 #1

    In 2026, Best in KLAS® ranked Sentri7 Pharmacy #1 for Pharmacy Surveillance. KLAS Research, which evaluates the performance of healthcare technology providers, recognized Sentri7 as a market leader for hospitals and health systems focused on optimizing pharmacy operations and infection prevention programs.

  • Real-time monitoring for opioid-related adverse drug events

    Sentri7 continuously monitors your patient population to find opportunities to employ multi-modal therapies to avoid over-sedation events and reduce side effects associated with opioids. You can also look for opportunities to discontinue or de-escalate opioid use. Configure alerts to support pharmacists in optimizing medication selection, dosing, and potential interventions.

  • Real-time MME calculations

    Sentri7 Opioid Stewardship automatically calculates each patient's total MME in real time, eliminating manual error. As clinical data flows through your existing feeds, the platform aggregates all opioids a patient receives across drug types, strengths, and routes, converting them into a single, standardized MME value that updates continuously.

    This live MME data empowers pharmacy teams to act before harm occurs. Evidence-based clinical rules surface high-MME patients and key risk indicators, so clinicians can intervene quickly by adjusting doses, changing routes, or introducing multi-modal therapy, supporting safer prescribing and alignment with The Joint Commission's opioid stewardship standards.

  • Actionable insights that improve performance and compliance

    Interactive Opioid Stewardship analytics dashboard provides real-time monitoring of your facility or in your hospital system, quantifying opioid use at the patient and population level by patient, drug, prescriber/specialty, care location or entire facility, safety metrics (ex. MME>90, naloxone administration), and to review concurrent prescribing (ex. opioid + benzodiazepine exposure). Stay aligned and compliant with the Joint Commission's requirements.

  • A trusted partner in pharmacy surveillance

    Sentri7 is more than a technology solution—it’s a trusted partner in advancing your pharmacy program. Backed by multidisciplinary support tailored to your goals, Sentri7 helps teams work more efficiently, surface at-risk patients faster, and elevate the impact of pharmacy surveillance.

Real-time MME calculations, evidence-based guidelines, and proactive risk identification.

Give pharmacy teams the tools to protect patients from opioid-related adverse drug events and simplify compliance.
  • Customer Success

  • Expert Insights

two doctors talking on stairway landing
Establishing opioid stewardship guidelines across a health system: Steward Health Care’s success 
Slowing the ever-growing opioid crisis begins in the hospital. In most cases, opioid stewardship guidelines are heavily focused on outpatient treatment areas and emergency departments.

Yes, I'd like a demo of Sentri7 for our opioid stewardship program! 

Interested in how Sentri7 can transform your hospital’s opioid stewardship program?

Sentri7 can support:

  • Real-time identification of patients at risk of opioid-related adverse drug effects.
  • Support safer dosing practices with clinically maintained algorithms for calculating MMEs.
  • Improved compliance with The Joint Commission’s pain management standards.
Back To Top